Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2013 1
2014 2
2018 1
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases.
Bizzaro N, Villalta D, Bini V, Migliorini P, Franceschini F, Piantoni S, Garrafa E, Riccieri V, Fioravanti A, Bellisai F, Tampoia M, Fornaro M, Iannone F, Ghirardello A, Zen M, Palterer B, Parronchi P, Infantino M, Benucci M, Rigon A, Arcarese L, Del Rosso S, Canti V, Bartoloni E, Gerli R; FIRMA Collaborators. Bizzaro N, et al. Among authors: arcarese l. Arthritis Res Ther. 2022 Dec 23;24(1):278. doi: 10.1186/s13075-022-02980-x. Arthritis Res Ther. 2022. PMID: 36564813 Free PMC article.
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles.
Navarini L, Vomero M, Currado D, Berardicurti O, Biaggi A, Marino A, Bearzi P, Corberi E, Rigon A, Arcarese L, Leuti A, Fava M, Fogolari M, Mattei A, Ruscitti P, Di Cola I, Sambuco F, Travaglino F, Angeletti S, Ursini F, Mariani E, Cipriani P, Agrò FE, Iagnocco A, Antonelli Incalzi R, Maccarrone M, Giacomelli R. Navarini L, et al. Among authors: arcarese l. Front Immunol. 2023 Apr 21;14:1148268. doi: 10.3389/fimmu.2023.1148268. eCollection 2023. Front Immunol. 2023. PMID: 37153620 Free PMC article.
Autoantibody status according to multiparametric assay accurately estimates connective tissue disease classification and identifies clinically relevant disease clusters.
Cafaro G, Bartoloni E, Baldini C, Franceschini F, Riccieri V, Fioravanti A, Fornaro M, Ghirardello A, Palterer B, Infantino M, Rigon A, Del Rosso S, Gerli R, Villalta D, Bizzaro N; FIRMA (Interdisciplinary Forum for the Research on Autoimmune Diseases) Collaborators; FIRMA Collaborators. Cafaro G, et al. RMD Open. 2023 Sep;9(3):e003365. doi: 10.1136/rmdopen-2023-003365. RMD Open. 2023. PMID: 37734871 Free PMC article.
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes".
Berardicurti O, Navarini L, Vomero M, Currado D, Biaggi A, Marino A, Bearzi P, Corberi E, Rigon A, Arcarese L, Vadacca M, Mattei A, Agrò FE, Incalzi RA, Sambuco F, Travaglino F, Ruscitti P, Cipriani P, Giacomelli R. Berardicurti O, et al. Among authors: arcarese l. Autoimmun Rev. 2023 May;22(5):103309. doi: 10.1016/j.autrev.2023.103309. Epub 2023 Mar 6. Autoimmun Rev. 2023. PMID: 36889656 Free PMC article.
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia.
Navarini L, Currado D, Pilato A, Marino A, Biaggi A, Di Donato S, Berardicurti O, Vomero M, Kun L, Arcarese L, Rigon A, Vadacca M, Bearzi P, Ruscitti P, Cipriani P, Iagnocco A, Giacomelli R. Navarini L, et al. Among authors: arcarese l. Clin Exp Rheumatol. 2023 Dec 4. doi: 10.55563/clinexprheumatol/3bs6em. Online ahead of print. Clin Exp Rheumatol. 2023. PMID: 38079327
Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.
D'Angelo S, Tirri E, Giardino AM, Mattucci-Cerinic M, Dagna L, Santo L, Ciccia F, Frediani B, Govoni M, Bobbio Pallavicini F, Grembiale RD, Delle Sedie A, Mulè R, Cantatore FP, Foti R, Gremese E, Conigliaro P, Salaffi F, Viapiana O, Cauli A, Giacomelli R, Arcarese L, Guggino G, Russo R, Puenpatom A, Capocotta D, Nacci F, Anelli MG, Picerno V, Binetti C, Iannone F. D'Angelo S, et al. Among authors: arcarese l. J Clin Med. 2022 Jul 19;11(14):4178. doi: 10.3390/jcm11144178. J Clin Med. 2022. PMID: 35887946 Free PMC article.
Real-world effectiveness and persistence of golimumab as second-line anti-TNFα drug in rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis patients in Italy: GO-BEYOND, a 12-month prospective observational study.
D'Angelo S, Tirri E, Giardino AM, De Rosa T, Matucci-Cerinic M, Dagna L, Santo L, Ciccia F, Frediani B, Govoni M, Pallavicini FB, Grembiale RD, Sedie AD, Mulè R, Cantatore FP, Foti R, Gremese E, Conigliaro P, Salaffi F, Viapiana O, Cauli A, Giacomelli R, Arcarese L, Guggino G, Russo R, Puenpatom A, Capocotta D, Nacci F, Anelli MG, Picerno V, Binetti C, Iannone F; GO-BEYOND Italy Study Investigators. D'Angelo S, et al. Among authors: arcarese l. Int J Rheum Dis. 2024 Mar;27(3):e15091. doi: 10.1111/1756-185X.15091. Int J Rheum Dis. 2024. PMID: 38433479 No abstract available.
13 results